Literature DB >> 26781462

Analysis of changes in expression of IL-4/IL-13/STAT6 pathway and correlation with the selected clinical parameters in patients with atopic asthma.

Adam Antczak1, Daria Domańska-Senderowska2, Paweł Górski3, Dorota Pastuszak-Lewandoska4, Agnieszka Nielepkowicz-Goździńska1, Karolina Szewczyk4, Zofia Kurmanowska4, Justyna Kiszałkiewicz4, Ewa Brzeziańska-Lasota4.   

Abstract

INTRODUCTION: Asthma is associated with activation of interleukin-4 (IL-4)/interleukin-13 (IL-13)/signal transducer and activator of transcription factor-6(STAT6) inflammatory response via overexpression of all pathway components: IL-4, IL-13, and STAT6.
OBJECTIVES: To evaluate the association of IL-4, IL-13, and STAT6 expression and immunoexpression with atopic asthma development. PATIENTS AND METHODS: Fifty patients with atopic asthma and 20 healthy controls were enrolled into the study. Relative gene expression was analyzed by qPCR method. Immunoexpression was assessed by ELISA method.
RESULTS: The expression levels of IL-4, IL-13, and STAT6 were higher in patients compared to the controls, but a statistically significant difference was observed only for IL-13 (P = 0.03). In immunoexpression analysis, a statistically significant difference between patients and controls was found for IgE (P = 0.03). Significant positive correlations in the patient group were found between IL-13 gene expression and total level of serum IgE (rho = 0.230, P = 0.033), STAT6 gene/STAT6 protein and total level of serum IgE (STAT6: rho = 0.077, P = 0.038; STAT6: rho = 0.049, P = 0.042), IL-4, and STAT6 expression (rho = 0.098, P = 0.048). Any significant correlations were found between expression/immunoexpression levels of the studied genes and clinical classification, clinical features, or lung function parameters.
CONCLUSIONS: Our data support the role of Th2 cytokines (IL-4, IL-13) and STAT6 in Th1/Th2 imbalance and highlight the etiological relationship between IL-4/IL-13/STAT6 signaling and atopy and asthma.
© The Author(s) 2016.

Entities:  

Keywords:  IL-4; Il-13; STAT6; atopic asthma

Mesh:

Substances:

Year:  2016        PMID: 26781462      PMCID: PMC5806727          DOI: 10.1177/0394632015623794

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  44 in total

Review 1.  The importance of genetic influences in asthma.

Authors:  H Los; G H Koppelman; D S Postma
Journal:  Eur Respir J       Date:  1999-11       Impact factor: 16.671

Review 2.  Atopy and asthma: genetic variants of IL-4 and IL-13 signalling.

Authors:  I Shirakawa; K A Deichmann; I Izuhara; I Mao; C N Adra; J M Hopkin
Journal:  Immunol Today       Date:  2000-02

Review 3.  [Inflammatory cytokines (IL-4, IL-5 and IL-13)].

Authors:  S Maeda; Y Yanagihara
Journal:  Nihon Rinsho       Date:  2001-10

Review 4.  Gene-environment interactions in the development of asthma and atopy.

Authors:  Adnan Custovic; Susana Marinho; Angela Simpson
Journal:  Expert Rev Respir Med       Date:  2012-06       Impact factor: 3.772

5.  Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes.

Authors:  Maritta Pykäläinen; Riikka Kinos; Sanna Valkonen; Pia Rydman; Maritta Kilpeläinen; Lauri A Laitinen; Jussi Karjalainen; Markku Nieminen; Mikko Hurme; Juha Kere; Tarja Laitinen; Riitta Lahesmaa
Journal:  J Allergy Clin Immunol       Date:  2005-01       Impact factor: 10.793

6.  The role of IL-13 in IgE synthesis by allergic asthma patients.

Authors:  T C Van der Pouw Kraan; J S Van der Zee; L C Boeije; E R De Groot; S O Stapel; L A Aarden
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Genetic variants of IL-13 signalling and human asthma and atopy.

Authors:  A Heinzmann; X Q Mao; M Akaiwa; R T Kreomer; P S Gao; K Ohshima; R Umeshita; Y Abe; S Braun; T Yamashita; M H Roberts; R Sugimoto; K Arima; Y Arinobu; B Yu; S Kruse; T Enomoto; Y Dake; M Kawai; S Shimazu; S Sasaki; C N Adra; M Kitaichi; H Inoue; K Yamauchi; N Tomichi; F Kurimoto; N Hamasaki; J M Hopkin; K Izuhara; T Shirakawa; K A Deichmann
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

8.  Association between candidate genes and lung function growth in Chinese asthmatic children.

Authors:  T F Leung; I H S Chan; G W K Wong; C Y Li; N L S Tang; E Yung; C W K Lam
Journal:  Clin Exp Allergy       Date:  2007-10       Impact factor: 5.018

Review 9.  Interleukin-4 receptor signaling pathways in asthma pathogenesis.

Authors:  Talal A Chatila
Journal:  Trends Mol Med       Date:  2004-10       Impact factor: 11.951

10.  Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.

Authors:  Janet S Lee; Matthew R Rosengart; Venkateswarlu Kondragunta; Yingze Zhang; Jessica McMurray; Robert A Branch; Augustine M K Choi; Frank C Sciurba
Journal:  Respir Res       Date:  2007-09-14
View more
  9 in total

Review 1.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 2.  Interleukin 4: Its Role in Hypertension, Atherosclerosis, Valvular, and Nonvalvular Cardiovascular Diseases.

Authors:  Kamal M Kassem; Mahboob Ali; Nour-Eddine Rhaleb
Journal:  J Cardiovasc Pharmacol Ther       Date:  2019-08-11       Impact factor: 2.457

Review 3.  Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.

Authors:  Pio Conti; Francesco Carinci; Gianfranco Lessiani; Enrico Spinas; Spyridon K Kritas; Gianpaolo Ronconi; Alessandro Caraffa; Theoharis C Theoharides
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

4.  Pilot-Scale Study Of Human Plasma Proteomics Identifies ApoE And IL33 As Markers In Atopic Asthma.

Authors:  Moumita Bhowmik; Sreyashi Majumdar; Angira Dasgupta; Swati Gupta Bhattacharya; Sudipto Saha
Journal:  J Asthma Allergy       Date:  2019-09-20

5.  Evolution of Th2 responses: characterization of IL-4/13 in sea bass (Dicentrarchus labrax L.) and studies of expression and biological activity.

Authors:  Valentina Stocchi; Tiehui Wang; Elisa Randelli; Massimo Mazzini; Marco Gerdol; Alberto Pallavicini; Chris J Secombes; Giuseppe Scapigliati; Francesco Buonocore
Journal:  Sci Rep       Date:  2017-05-22       Impact factor: 4.379

6.  Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.

Authors:  Fatai S Oladunni; Jun-Gyu Park; Paula A Pino; Olga Gonzalez; Anwari Akhter; Anna Allué-Guardia; Angélica Olmo-Fontánez; Shalini Gautam; Andreu Garcia-Vilanova; Chengjin Ye; Kevin Chiem; Colwyn Headley; Varun Dwivedi; Laura M Parodi; Kendra J Alfson; Hilary M Staples; Alyssa Schami; Juan I Garcia; Alison Whigham; Roy Neal Platt; Michal Gazi; Jesse Martinez; Colin Chuba; Stephanie Earley; Oscar H Rodriguez; Stephanie Davis Mdaki; Katrina N Kavelish; Renee Escalona; Cory R A Hallam; Corbett Christie; Jean L Patterson; Tim J C Anderson; Ricardo Carrion; Edward J Dick; Shannan Hall-Ursone; Larry S Schlesinger; Xavier Alvarez; Deepak Kaushal; Luis D Giavedoni; Joanne Turner; Luis Martinez-Sobrido; Jordi B Torrelles
Journal:  Nat Commun       Date:  2020-11-30       Impact factor: 14.919

7.  Opuntia humifusa modulates morphological changes characteristic of asthma via IL-4 and IL-13 in an asthma murine model.

Authors:  Soon-Young Lee; Chun-Sik Bae; Young-Hoon Choi; Nam-Sook Seo; Chang-Su Na; Jin-Cheol Yoo; Seung Sik Cho; Dae-Hun Park
Journal:  Food Nutr Res       Date:  2017-10-24       Impact factor: 3.894

8.  Macmoondongtang modulates Th1-/Th2-related cytokines and alleviates asthma in a murine model.

Authors:  Soon-Young Lee; Bossng Kang; So-Hyeon Bok; Seung Sik Cho; Dae-Hun Park
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

Review 9.  Recent Advances in the Inhibition of the IL-4 Cytokine Pathway for the Treatment of Allergen-Induced Asthma.

Authors:  Oliver Massey; Cenk Suphioglu
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.